Heart surgery kidney risk: could a different drug save more lives?
NCT ID NCT05568160
First seen Jan 07, 2026 · Last updated May 13, 2026 · Updated 18 times
Summary
This study compares two drugs, vasopressin and noradrenaline, used to maintain blood pressure after heart surgery. The goal is to see if vasopressin reduces the number of patients who develop acute kidney failure or die, compared to the standard drug noradrenaline. The trial includes 840 adults undergoing scheduled heart surgery with a heart-lung machine. Participants are followed for 90 days after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASOPLEGIC SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chu Dijon Bourgogne
Dijon, France
Conditions
Explore the condition pages connected to this study.